Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102
Clinical trial NCT03679754 · COMPLETED
Trial details
- NCT number
- NCT03679754
- Sponsor
- Alaunos Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-05
- Primary completion
- 2019-04-02
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.